Please use this identifier to cite or link to this item:
Title: Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
Authors: Aisanov, Zaurbek
Avdeev, Sergey
Arkhipov, Vladimir
Belevskiy, Andrey
Chuchalin, Alexander
Leshchenko, Igor
Ovcharenko, Svetlana
Shmelev, Evgeny
Miravitlles, Marc
Issue Date: 2018
Publisher: Dove Medical Press Limited
Citation: Aisanov Zaurbek, Avdeev Sergey, Arkhipov Vladimir, Belevskiy Andrey, Chuchalin Alexander, Leshchenko Igor, Ovcharenko Svetlana, Shmelev Evgeny, Miravitlles Marc. Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. International Journal of COPD. - 2018. -№13. – pp. 183-187
Abstract: The high prevalence of COPD together with its high level of misdiagnosis and late diagnosis dictate the necessity for the development and implementation of clinical practice guidelines (CPGs) in order to improve the management of this disease. High-quality, evidencebased international CPGs need to be adapted to the particular situation of each country or region. A new version of the Russian Respiratory Society guidelines released at the end of 2016 was based on the proposal by Global Initiative for Obstructive Lung Disease but adapted to the characteristics of the Russian health system and included an algorithm of pharmacologic treatment of COPD. The proposed algorithm had to comply with the requirements of the Russian Ministry of Health to be included into the unified electronic rubricator, which required a balance between the level of information and the simplicity of the graphic design. This was achieved by: exclusion of the initial diagnostic process, grouping together the common pharmacologic and nonpharmacologic measures for all patients, and the decision not to use the letters A–D for simplicity and clarity. At all stages of the treatment algorithm, efficacy and safety have to be carefully assessed. Escalation and de-escalation is possible in the case of lack of or insufficient efficacy or safety issues. Bronchodilators should not be discontinued except in the case of significant side effects. At the same time, inhaled corticosteroid (ICS) withdrawal is not represented in the algorithm, because it was agreed that there is insufficient evidence to establish clear criteria for ICSs discontinuation. Finally, based on the Global Initiative for Obstructive Lung Disease statement, the proposed algorithm reflects and summarizes different approaches to the pharmacological treatment of COPD taking into account the reality of health care in the Russian Federation.
Keywords: COPD
Origin: International Journal of COPD
Appears in Collections:Публикации в журналах, альманахах

Files in This Item:
File Description SizeFormat 
NP_2022_049.pdf348,3 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.